Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Gilead sciences, inc. crawled time : 21:00 save search
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
Published: 2024-02-28 (Crawled : 21:00) - prnewswire.com
ACLX | $54.575 1.91% 130K
|
|
| O: 3.09%
H: 0.94%
C: -5.16%
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: 0.03%
H: 0.26%
C: -0.85%
business financial results
Arcellx Announces Continued Robust Long-Term Responses from Its CART-ddBCMA (anito-cel) Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at ASH
Published: 2023-12-08 (Crawled : 21:00) - prnewswire.com
ACLX | $54.575 1.91% 130K
|
| Email alert
Add to watchlist
GILD | $66.2 -1.09% 3.3M
|
Health Technology
| Email alert
Add to watchlist
expansion trial
THE BLACK WOMEN'S AGENDA, INC. HOSTS 46TH ANNUAL SYMPOSIUM TOWN HALL & AWARDS LUNCHEON
Published: 2023-09-22 (Crawled : 21:00) - prnewswire.com
GILD | $66.2 -1.09% 3.3M
|
Health Technology
| Email alert
Add to watchlist
symposium awards
Gilead Announces $8 Million in Grant Funding for Viral Hepatitis Relink Program in the U.S.
Published: 2023-07-20 (Crawled : 21:00) - biospace.com/
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: 0.76%
H: 1.53%
C: 0.48%
hepatitis grant program funding
MacroGenics Provides Corporate Update and 2022 Financial Results
Published: 2023-03-15 (Crawled : 21:00) - globenewswire.com
MGNX | $16.27 1.06% 140K
|
Health Technology
|
| O: 8.04%
H: 9.34%
C: 2.04%
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: -0.59%
H: 1.0%
C: 0.85%
update financial results
2023 CALIFORNIA CONFERENCE FOR WOMEN TO FOCUS ON LEADERSHIP, CONNECTION, AND BEING A FORCE FOR CHANGE
Published: 2023-02-08 (Crawled : 21:00) - prnewswire.com
STT 4 | $73.0 0.26% 610K
|
Finance
|
| O: 0.21%
H: 0.74%
C: -1.34%
JNPR | $36.255 -0.62% 3.7M
|
Technology Services
|
| O: 0.87%
H: 0.22%
C: -1.15%
JNJ | News | $144.54 -0.16% 4.9M
|
Health Technology
|
| O: 0.01%
H: 0.71%
C: -1.36%
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: 0.19%
H: 0.9%
C: -0.35%
california conference women change
Hagens Berman Sobol Shapiro LLP, Hilliard & Shadowen LLP, and Durie Tangri LLP Announce a Class Action Involving Antiretroviral Drugs
Published: 2022-12-28 (Crawled : 21:00) - prnewswire.com
JNJ | News | $144.54 -0.16% 4.9M
|
Health Technology
|
| O: 0.5%
H: 0.42%
C: 0.01%
BMY | $47.895 0.12% 4.6M
|
Health Technology
|
| O: 0.43%
H: 0.47%
C: -0.28%
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: 0.4%
H: 0.78%
C: 0.41%
Lyndra Therapeutics’ LYNX™ Drug Delivery Platform Wins 2022 Fierce Life Sciences Innovation Award for Drug Delivery Technology
Published: 2022-11-15 (Crawled : 21:00) - biospace.com/
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: 0.34%
H: 0.61%
C: -0.16%
award sciences drug life technology innovation platform
Assembly Bio Announces Retirement of John G. McHutchison, AO, MD as CEO and Appoints Current President and COO Jason A. Okazaki as Successor
Published: 2022-10-05 (Crawled : 21:00) - investor.assemblybio.com
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: -0.86%
H: 0.72%
C: 0.09%
ASMB | $12.95 0.23% 15K
|
Health Technology
|
| O: 4.73%
H: 1.13%
C: -3.95%
ceo
Gilead Sciences Contributes Additional $85 Million to Its Foundation to Advance Health Equity
Published: 2022-07-20 (Crawled : 21:00) - biospace.com/
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: -1.01%
sciences health
Gilead Sciences to Release Second Quarter 2022 Financial Results on Tuesday, August 2, 2022
Published: 2022-07-12 (Crawled : 21:00) - biospace.com/
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: -0.27%
H: 0.5%
C: -0.24%
sciences results
Gilead and Kite Oncology Demonstrate Broad Leadership in Cell Therapy and Expanding Blood Cancer Pipeline
Published: 2021-11-04 (Crawled : 21:00) - biospace.com/
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: -0.43%
H: 0.04%
C: -0.97%
blood therapy cancer
Rafael Holdings Continues to Expand its Management Team with a Highly Experienced Global Biopharmaceutical Executive to Build a Fully Integrated Cancer Metabolism Therapeutics Company and Announces Inducement Grant Under NYSE Rule 303A.08
Published: 2021-09-24 (Crawled : 21:00) - prnewswire.com
BDX | $230.84 -0.59% 300K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
| Email alert
Add to watchlist
RFL 4 | $1.735 -2.53% 5.2K
|
Finance
| Email alert
Add to watchlist
GILD | $66.2 -1.09% 3.3M
|
Health Technology
| Email alert
Add to watchlist
biopharma cancer
IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-09 (Crawled : 21:00) - igmbio.com
IGMS | News | $7.69 -5.41% 120K
|
Health Technology
|
| O: 0.51%
H: 7.28%
C: 5.3%
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: 0.0%
H: 0.71%
C: -0.47%
financial results results bioscience
Guardant Health Announces Appointment of Chris Freeman as Chief Commercial Officer
Published: 2021-06-08 (Crawled : 21:00) - biospace.com/
GH M | $16.72 2.01% 850K
|
Health Services
|
| O: 1.97%
H: 0.56%
C: -3.4%
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: 0.03%
H: 0.25%
C: 0.1%
health commercialization
AlloVir Appoints Diana M. Brainard, M.D., as Chief Executive Officer, Effective May 17, 2021
Published: 2021-03-22 (Crawled : 21:00) - biospace.com/
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: -0.63%
H: 2.51%
C: 2.3%
ALVR | $0.75 -0.91% 230K
|
Health Technology
|
| O: 1.14%
H: 3.15%
C: -0.27%
Gilead’s Investigational Lenacapavir Demonstrates Sustained Long-Acting Efficacy Through Week 26 in Data Presented at CROI
Published: 2021-03-09 (Crawled : 21:00) - biospace.com/
GILD | $66.2 -1.09% 3.3M
|
Health Technology
|
| O: 1.17%
H: 1.75%
C: -1.8%
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.